LLC J.H. Whitney Equity Partners Vii Reduces Stake in AVAH

LLC J.H. Whitney Equity Partners Vii recently sold a significant portion of its holdings in AVAH. On June 24, 2026, the firm sold 919,389 shares at an average price of $8 each, totaling approximately $7.36 million. This transaction was not made under a pre-planned trading scheme.

Other Institutional Activity in AVAH

Several other institutional investors have also made moves regarding AVAH. Bain Capital Investors LLC maintained its large stake, holding steady at 81,600,880 shares valued at about $525.5 million. Nut Tree Capital Management, LP increased its position by 550,000 shares, bringing its total to 12,922,649 shares worth approximately $83.2 million, a 4.4% increase. Conversely, BlackRock, Inc. reduced its holdings by 656,532 shares, now holding 5,500,912 shares valued at around $35.4 million, marking a 10.7% decrease. Summit Partners L P also trimmed its position by 2,100,000 shares, ending with 5,451,422 shares worth about $35.1 million, a 27.8% decrease. Meanwhile, Vanguard Capital Management LLC opened a new position with 3,974,819 shares valued at approximately $25.6 million.

Aveanna Healthcare Holdings Inc. Stock Down 36.3%

Shares of AVAH traded near $8.48 on Friday. The company has seen varied institutional interest and analyst attention recently, which could influence its market performance.

Insider Buying and Selling at Aveanna Healthcare Holdings Inc.

In addition to LLC J.H. Whitney Equity Partners Vii's sale, other insiders have been active. On June 24, 2026, Paul Vigano and Robert Williams Jr. each sold 1,000,000 shares at $8 per share. Earlier in the month, on June 3, 2026, both Vigano and Williams sold 7,000,000 shares each at $6.24 per share. LLC J.H. Whitney Equity Partners Vii also sold 5,842,240 shares on the same day at $6.24 per share.

Analysts Set New Price Targets

Analyst firms have been updating their views on AVAH. On May 18, 2026, Barclays maintained its buy rating with a $9 target. Stephens & Co. upgraded the stock to a buy on May 15, 2026, setting a target of $11. RBC Capital maintained a hold rating with a $10 target on the same date. Truist Securities also maintained a hold with an $8 target on April 13, 2026. Overall, the consensus leans towards a buy recommendation with a mean target price around $9, based on multiple analyst opinions.

Bottom Line

LLC J.H. Whitney Equity Partners Vii's recent sale of AVAH shares highlights active trading by insiders and institutional investors. Investors keep a close watch on such transactions for potential insights into company performance and market sentiment. It's important to note that these insights are based on past transactions and may not reflect current positions.